MedGeneRx Logo 300x61 REG

Treatment of Chronic Wounds with Autologous Platelet-Rich-Plasma


After treatment with platelet-rich plasma, 50% of the wounds had healed, 35.7% had reduced in size and 14.2% were unchanged in terms of area and condition. Recurrencies were not observed during the follow-up period of an average of 34.5 weeks (range 6,5 weeks-52 weeks). Conclusion: The use of autologous platelet-rich plasma should be reserved for treatment of recalcitrant wounds where there is lack of improvement despite treatment of underlying causes and good local wound care.


We’re here to help your patients and your practice.

Through innovative technology, preparation & training.